Abu Lila, Amr S <br/><br/>
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?  [electronic resource] 

 -  International journal of pharmaceutics  Apr 2012 
 - 263-270 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2012.01.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Metronomic<br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--blood<br/>Biological Availability<br/>Cell Line, Tumor<br/>Chemistry, Pharmaceutical<br/>Colorectal Neoplasms--blood<br/>Drug Antagonism<br/>Drug Combinations<br/>Drug Compounding<br/>Drug Synergism<br/>Injections, Intravenous<br/>Liposomes<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Nanotechnology<br/>Neovascularization, Pathologic--blood<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Oxonic Acid--administration & dosage<br/>Particle Size<br/>Polyethylene Glycols--chemistry<br/>Technology, Pharmaceutical--methods<br/>Tegafur--administration & dosage<br/>Tissue Distribution